# Qisheng Capital

> Qisheng Capital is a VC fund in Baoshan backing Biotechnology and Pharmaceutical. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Baoshan, China
- Total investments: 6
- Last investment: Jul 2026
- Lead investor: 0%
- Last updated: Aug 2026

Qisheng Capital is an investment firm that offer investment management and consulting service.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 50% |
| Pharmaceutical | 3 | 50% |
| Biopharma | 2 | 33% |
| Manufacturing | 2 | 33% |
| Electronics | 1 | 17% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 50% |
| Angel | 1 | 17% |
| Series C | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Yanming Biology | Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors. |  | Series B | Jul 03, 2026 |  |
| XellSmart | Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China. | $72.6M | Series C | Apr 01, 2026 |  |
| XellSmart | Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China. | $14M | Series B | Oct 21, 2024 |  |
| Fujian Technology | Futan Technology specializes in the research and development of isostatic graphite materials. | $13.7M | Series B | Aug 30, 2023 |  |
| Gloria spectrum | Gloria spectrum offers mass spectrometry applications as its core technology as well as multi-omics data-driven product innovation strategy. |  | Venture - Series Unknown | May 05, 2022 |  |
| Tongming | Tongming specializes in auto parts design and manufacturing services. | $425K | Angel | Apr 28, 2017 |  |

6 of 6 investments shown.

## Co-investors
- [Frees Fund](https://shizune.co/investors/profile/freesfund) — VC Fund, 2 deals together
- Shanghai Minjin Investment — VC Fund, 2 deals together
- Suzhou Angel Fund of Funds — VC Fund, 2 deals together
- [Beijing Medical and Health Industry Investment Fund](https://shizune.co/investors/profile/beijing-medical-and-health-industry-investment-fund) — VC Fund, 1 deal together
- Chang Development — VC Fund, 1 deal together
- China Win Fund — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Qisheng Capital invest in?

Qisheng Capital invests primarily in Biotechnology, Pharmaceutical and Biopharma startups, most often at Series B and Angel stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Qisheng Capital last invest?

The most recent investment recorded for Qisheng Capital closed in Jul 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co